Screener
Bio-Techne TECH Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056302
| Line item | March 31, 2026 / (unaudited) | June 30, 2025 |
|---|---|---|
| Income taxes payable | 2,971 | 10,770 |
| Operating lease liabilities - current | 14,181 | 14,098 |
| Other current liabilities | 2,092 | 1,645 |
| Total current liabilities | 153,278 | 175,849 |
| Deferred income taxes | 14,210 | 6,169 |
| Long-term debt obligations | 200,000 | 346,000 |
| Operating lease liabilities | 76,141 | 83,960 |
| Other long-term liabilities | 21,668 | 27,082 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Bio-Techne's total current liabilities?
- Bio-Techne (TECH) reported total current liabilities of $153.28M in Q1 2026.
- How has Bio-Techne's total current liabilities changed year-over-year?
- Bio-Techne's total current liabilities decreased by 9.4% year-over-year, from $169.2M to $153.28M.
- What is the long-term trend for Bio-Techne's total current liabilities?
- Over 4 years (2021 to 2025), Bio-Techne's total current liabilities has grown at a 3.7% compound annual growth rate (CAGR), from $152.28M to $175.85M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Bio-Techne's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude